The Attitudes and Beliefs of Hispanic/Latino Individuals Toward Prescription Opioids and Non-Medical Opioid Use

NCT ID: NCT05529082

Last Updated: 2024-08-02

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

WITHDRAWN

Study Classification

OBSERVATIONAL

Study Start Date

2023-03-23

Study Completion Date

2024-07-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

To better understand how people think and feel about prescribed pain medication, including opioids.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

OBJECTIVES:

Primary Objectives:

1\. To examine the general attitudes and beliefs of Hispanic/Latino individuals about the use of prescription opioids. The primary outcomes include the responses to questions 13-28 from the Opioid Attitudes and Beliefs survey.

Secondary

1. To evaluate Hispanic/Latino individuals' reports of personal experiences with the use of opioids. The corresponding outcomes are the responses to questions 1-12 from the Opioid Attitudes and Beliefs survey.
2. To find out any potential reasons why some Hispanic/Latino individuals may refuse to use clinically indicated opioid prescriptions. These outcomes are the responses to questions 14-15 from the Opioid Attitudes and Beliefs survey.
3. To explore factors associated with participant's comfort with the use opioid analgesics for their pain. The outcome will be the association between participants' responses to question 2 and their characteristics such as age, gender, race, level of education, extent of acculturation, knowledge of opioids, or previous opioid use.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Opioids

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Opioid Attitudes and Beliefs survey

Participants will complete a questionnaire about your feelings/beliefs on prescription pain medication and your experience with opioids/pain medication. Demographic information about you (such as your age, gender, race, ethnicity, and so on) will also be collected.

Opioid Attitudes

Intervention Type OTHER

Participants will complete a questionnaire about your feelings/beliefs on prescription pain medication and your experience with opioids/pain medication. Demographic information about you (such as your age, gender, race, ethnicity, and so on) will also be collected.

Beliefs survey

Intervention Type OTHER

Participants will complete a questionnaire about your feelings/beliefs on prescription pain medication and your experience with opioids/pain medication. Demographic information about you (such as your age, gender, race, ethnicity, and so on) will also be collected.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Opioid Attitudes

Participants will complete a questionnaire about your feelings/beliefs on prescription pain medication and your experience with opioids/pain medication. Demographic information about you (such as your age, gender, race, ethnicity, and so on) will also be collected.

Intervention Type OTHER

Beliefs survey

Participants will complete a questionnaire about your feelings/beliefs on prescription pain medication and your experience with opioids/pain medication. Demographic information about you (such as your age, gender, race, ethnicity, and so on) will also be collected.

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

1. Aged 18 years or older.
2. Ability to understand, read, write, or speak English and/or Spanish.
3. Ability to give informed consent.
4. Willingness to participate in the survey.

Exclusion Criteria

1\. Refusal to participate in the study
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

National Institutional of Health

UNKNOWN

Sponsor Role collaborator

UT Health Science Center

UNKNOWN

Sponsor Role collaborator

M.D. Anderson Cancer Center

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Joseph Arthur, MD

Role: PRINCIPAL_INVESTIGATOR

M.D. Anderson Cancer Center

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

M D Anderson Cancer Center

Houston, Texas, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

Related Links

Access external resources that provide additional context or updates about the study.

http://www.mdanderson.org

M D Anderson Cancer Center

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

NCI-2022-06839

Identifier Type: OTHER

Identifier Source: secondary_id

2022-0543

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Opioids and Smoking Cessation
NCT03857139 WITHDRAWN PHASE4